Susceptibilities of Candida albicans Mouth Isolates to Antifungal Agents, Essentials Oils and Mouth Rinses Authors
First Online: 14 January 2012 Received: 24 June 2011 Accepted: 02 January 2012 DOI:
Cite this article as: Carvalhinho, S., Costa, A.M., Coelho, A.C. et al. Mycopathologia (2012) 174: 69. doi:10.1007/s11046-012-9520-4 Abstract
Candida albicans strains isolated from patient’s mouth with fixed orthodontic appliances were analyzed to their susceptibilities to antifungal agents, mouth rinses and essential oils. Susceptibility to fluconazole, econazole, miconazole and ketoconazole, amphotericin B and nystatin was assessed by the disk diffusion (DD) method based on the Clinical and Laboratory Standards Institute M44-A protocol, and by Etest (fluconazole and amphotericin B). The susceptibilities to mouth rinses and essential oils were also determined by the DD technique. All isolates tested were susceptible (S) to amphotericin B, nystatin and fluconazole. The overall concordance between the DD and the Etest was 100% for amphotericin and fluconazole. One isolate was resistant to econazole (2.5%) and the other to ketoconazole (2.5%). Econazole and ketoconazole had the highest percentages of susceptible dose dependent (SDD), 55 and 95%, respectively. Regarding to the susceptibility isolates profile, seven phenotypes were detected, and the 3 more represented (90% of the isolates) of them were SDD to one, two or three azoles. The study of mouth rinses showed a high variability of efficacy against C. albicans. The results showed that the isolates susceptibility to essential oils differed ( P < 0.05). The profile activity was: cinnamon > laurel > mint > eucalyptus > rosemary > lemon > myrrh > tangerine. The main finding was that the susceptibility to cinnamon and laurel varied among the three more representative antifungal phenotypes ( P < 0.05). The susceptibility of econazole-SDD isolates to cinnamon and lemon was higher than those of the econazole-S yeasts ( P < 0.05). In contrast, econazole-SDD isolates were less affected by laurel than econazole-S counterparts ( P < 0.05). Keywords Candida albicans Susceptibility Antifungal Essential oils Mouth rinses References
Farias N, Buffon M, Cini R. In vitro evaluation of antifungal action of chlorhexidine digluconate and nystatin on the growing control of
Candida albicans. Visão Acadêmica Curitiba. 2003;4:83–8.
Budtz-Jorgensen E. Etiology, pathogenesis, therapy and prophylaxis of yeast infection. Acta Odontol Scand. 1990;48:61–9.
Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol. 1994;78:211–5.
Candida and Candidosis. In: Odds F, editor. Factors that predispose the host to candidosis. 2nd ed. London: Bailiière Tindal; 1988. p. 71–4.
Pinto PM, Weikert-Oliveira RCB, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA. In vitro antifungal susceptibility of clinical isolates of
spp. obtained from patients with different predisposing factors to candidosis. Microbiol Res. 2008;163:579–85.
Klepser ME. Antifungal resistance among Candida species. Pharmacother. 2001;21:124S–32S.
Khan ZU, Chandy R, Metwali KE.
strain carriage in patients and nursing staff of an intensive care unit: a study of morphotypes and resistotypes. Mycoses. 2003;46:476–86.
Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral
to seven antifungal agents. Oral Microbiol Immunol. 2005;20:349–53.
Paniagua GLC, Monroy EP, Negrete EA, Vaca SP. Susceptibility to 5-Fluorocytosine, miconazole and amphotericin B of
strains isolated from the throat of non-AIDS patients. Rev Latinoam Microbiol. 2002;44:65–8.
Manfredi M, McCullough MJ, Polonelli L, Conti S, Al-Karaawi ZM, Vescovi P, Porter SR. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol. 2006;21:177–82.
Hiom SJ, Furr JR, Russel AD, Dickinson JR. Effects of chlorhexidine diacetate on
Candida albicans, C. glabrata and Saccharomyces cerevisiae. J Appl Bacteriol. 1992;72:35–40.
Giuliana G, Pizzo G, Milici E, Musotto GC, Giangreco R. In vitro antifungal properties of mouthrinses containing antimicrobial agents. J Periodontol. 1997;68:729–33.
Harper RP, Milsom S, Wade W, Addy M, Moran J, Newcombe RG. An approach to efficacy screening of mouthrinses: studies on a group of French products. (II). Inhibition of salivary bacteria and plaque in vivo. J Clin Periodontol. 1995;22:723–7.
Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils—a review. Food Chemical Toxicol. 2008;46:446–75.
Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol. 1999;86:985–90.
Giordani R, Regli P, Kaloustian J, Mikaïl C, Abou L, Portugal H. Antifungal effect of various essential oils against
. Potentiation of antifungal action of amphotericin B by essential oil from
. Phytother Res. 2004;18:990–5.
Cavaleiro C, Pinto E, Gonçalves MJ, Salgueiro L. Antifungal activity of
essential oils against dermatophyte,
strains. J Appl Microbiol. 2006;100:1333–8.
Kurtzman CP, Fell JW. The yeasts: a taxonomic study. 4th ed. Amsterdam: Elsevier; 1998.
Taschdjian CL. Routine identification of
: current methods on a new medium. Mycologia. 1957;49:332–8.
Brown AJ, Gow NA. Regulatory networks controlling
morphogenesis. Trends Microbiol. 1999;7:333–8.
NCCLS. Method for antifungal disk diffusion susceptibility testing for yeasts. Approved Guideline NCCLS Document M44-A. Pennsylvania; 2004.
Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 2002;46:1781–4.
Barry A, Bille J, Brown S, Ellis D, Meis J, Pfaller M, Rennie R, Rinaldi M, Rogers T, Traczewski M. Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol. 2003;41:3410–2.
StatSoft, Inc. STATISTICA (data analysis software system), version 9.1.
Hibino K, Wong RW, Hägg U, Samaranayake LP. The effects of orthodontic appliances on
in the human mouth. Int J Paediatr Dent. 2009;19:301–8.
Pai MB, Prashant GM, Murlikrishna KS, Shivakumar KM, Chandu GN. Antifungal efficacy of
: an in vitro study. Indian J Dent Res. 2010;21:334–6.
Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010;98:15–25.
Dar-Odeh N, Shehabi A. Oral candidosis in patients with removable dentures. Mycoses. 2003;46:187–91.
Dorocka-Bobkowska B, Konopka K. Susceptibility of
isolates from denture—related stomatitis to antifungal agents in vitro. Int J Prosthodont. 2007;20:504–6.
Arendrup M, Lundgren B, Jensen IM, Hansen BS, Frimodt-Møller N. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of
isolates. J Antimicrob Chemother. 2001;47:521–6.
Barasch A, Griffin AV. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol. 2008;3:265–9.
Marcos-Arias C, Eraso E, Madariaga L, Carrilo-Muñoz AJ, Quindós G. In vitro activities of new triazole antifungal agents posaconazole and voriconazole, against oral
isolates from patients suffering from denture stomatitis. Mycopathologia. 2012;173:35–46.
Giuliana G, Pizzo G, Milici E, Giangreco R. In vitro study of antimicrobial agents against
Candida species. Oral Surg Oral Med Oral Pathol. 1999;1:44–9.
Vianna M, Gomes B, Berber V, Zaia A, Ferraz C. In vitro evaluation of the antimicrobial activity of chlorhexidine and sodium hypoclorite. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:79–84.
Waltimo T, Haapasalo M, Zehnder M, Meyer J. Clinical aspects related to endodontic yeasts infections. Endod Topics. 2004;9:66–78.
Janssen AM, Chin NLJ, Scheffer JJC, Svendsen AB. Screening for antimicrobial activity of some essential oils by the agar overlay technique. Pharm Weekbl Sci Ed. 1986;8:289–92.
Abdel-Mallek AY, Bagy MMK, Hasan HAH. The in vitro anti-yeast activity of some essential oils. J Islam Acad Sci. 1994;7:10–2.
Ezzat SM. In vitro inhibition of
growth by plant extracts and essential oils. World J Microbiol Biotechnol. 2001;17:757–9.
Işcan G, Kirimer N, Kürkcüoğlu M, Başer KHC, Demirci F. Antimicrobial screening of
essential oils. J Agric Food Chem. 2002;50:3943–6.
Tampieri MP, Caluppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I. The inhibition of
by selected essential oils and their major components. Mycopathol. 2005;159:339–45.
Moreira ACP, Lima EO, Souza EL, Van Dingenen MA, Trajano VN. Inhibitory effect of
Blume (lauraceae) essential oil and β-pinene on the growth of dematiaceous moulds. Braz J Microbiol. 2007;38:33–8.
Pozzatti P, Loreto ES, Lopes PGM, Atayde ML, Santurio JM, Alves SH. Comparison of the susceptibilities of clinical isolates of
to essential oils. Mycoses. 2009;53:12–5.
Bullerman LB, Lieu FY, Sally AS. Inhibition of growth and aflatoxin production by cinnamon and clove oils, cinnamoldehyd and eugenol. J Food Sci. 1977;42:1107–8.
Cheng S-S, Liu J-Y, Hsui Y-R, Chang S-T. Chemical polymorphism and antifungal activity of essential oils from leaves of different provenances of indigenous cinnamon (
). Bioresour Technol. 2006;97:306–12.
Pozzatti P, Scheid LA, Spader TB, Atayde ML, Santurio JM, Alves SH. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible
spp. Can J Microbiol. 2008;54:950–6.
Devkatte AN, Zore GB, Karuppayil SM. Potential of plant oils as inhibitors of
growth. FEMS Yeast Res. 2005;5:867–73.
Farag RS, Daw ZY, Hewedi FM, El-Baroty GSA. Antimicrobial activity of some Egyptian spice essential oils. J Food Prot. 1989;52:665–7.
© Springer Science+Business Media B.V. 2012